Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction


Creative Commons License

ENHOŞ A. , KARAÇÖP E.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, vol.17, pp.441-452, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 17
  • Publication Date: 2021
  • Doi Number: 10.2147/tcrm.s307768
  • Title of Journal : THERAPEUTICS AND CLINICAL RISK MANAGEMENT
  • Page Numbers: pp.441-452
  • Keywords: acute myocardial infarction, aspirin, infarct size, primary prevention, PERCUTANEOUS CORONARY INTERVENTION, CARDIAC MAGNETIC-RESONANCE, LEFT-VENTRICULAR FUNCTION, PRIMARY PREVENTION, ADVERSE OUTCOMES, ELEVATION, TROPONIN, DISEASE, MORTALITY

Abstract

Background: The study aimed to evaluate the impact of antecedent aspirin use on infarct size, bleeding and composite endpoint in patients with de novo acute myocardial infarction.